Trial Profile
A Placebo-controlled, Double-blind, Randomized, Trial of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 26 Jun 2020
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Amzell
- 26 Jun 2021 Osteoarthritis of knee is not added as drug of focus is treating only pain associated with that,
- 06 Jun 2020 Primary endpoint has been met. (WOMAC pain sub-score)
- 06 Jun 2020 Results presented at the 21st Annual Congress of the European League Against Rheumatism